Phillip Lee, MD
Sleep Medicine · Mason City, IANPI 1083609317
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $8,125 of the $9,595 with a category attached, or 84.7%. Inspire Medical Systems, Inc. accounts for 94.9% of it on its own, with 11 other manufacturers making up the rest. Reporting peaked in 2023 at $6,934 and has fallen 97.3% since, to $184 in 2025.
Across 41 payments — averaging $234.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Inspire Medical Systems, Inc.$9K
- Itamar Medical Inc$157
- Stryker$55
- Sanofi$53
- Aerin Medical Inc.$46
- Regeneron Healthcare Solutions, Inc.$45
- plus $135 from 6 others
What the payments were for
- Consulting fees$8,12585%
- Travel & lodging$3033%
- Food & beverage$1,16712%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Inspire Medical Systems, Inc. | 21 | $9,104 |
| Itamar Medical Inc | 3 | $157 |
| Stryker | 2 | $55 |
| Sanofi | 3 | $53 |
| Aerin Medical Inc. | 2 | $46 |
| Regeneron Healthcare Solutions, Inc. | 2 | $45 |
| Resmed Corp | 2 | $41 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $26 |
| Intersect ENT, Inc. | 2 | $23 |
| Boston Scientific | 1 | $17 |
| Novartis | 1 | $15 |
| GSK | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Inspire$6,674
- Inspire Upper Airway Stimulation System$1,950
How this compares
Too few sleep medicine providers in Iowato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent SyringeDupilumab | 13 | $50,925 |
| Fluticasone Propionate | 594 | $6,338 |
| Azelastine Hcl | 176 | $5,410 |
| Ipratropium Bromide | 47 | $1,606 |
| Montelukast Sodium | 164 | $690 |
| Omeprazole | 15 | $4 |
Paid to pharmacies, not to this prescriber.
Other sleep medicine in Mason City
- Stephen GrantClive$153K
- Adekunle AjisebutuDes Moines$4K
- Steven ZornWest Des Moines$4K
- Ogechukwu ObianoIowa City$2K
- Likhita ShaikIowa City$2K
- Junjie LiuIowa City$2K
- Alexandra IannoneIowa City$1K
- Edward ClemmonsAmes$826
- Michael McCubbinPella$205
- Jade BrusseauIowa City$159
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.